1. Home
  2. YHC vs EVOK Comparison

YHC vs EVOK Comparison

Compare YHC & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YHC
  • EVOK
  • Stock Information
  • Founded
  • YHC 2021
  • EVOK 2007
  • Country
  • YHC United States
  • EVOK United States
  • Employees
  • YHC N/A
  • EVOK N/A
  • Industry
  • YHC Beverages (Production/Distribution)
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • YHC Consumer Staples
  • EVOK Health Care
  • Exchange
  • YHC Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • YHC 8.3M
  • EVOK 7.6M
  • IPO Year
  • YHC N/A
  • EVOK 2013
  • Fundamental
  • Price
  • YHC $0.88
  • EVOK $10.70
  • Analyst Decision
  • YHC
  • EVOK
  • Analyst Count
  • YHC 0
  • EVOK 0
  • Target Price
  • YHC N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • YHC 369.3K
  • EVOK 235.3K
  • Earning Date
  • YHC 11-12-2025
  • EVOK 11-07-2025
  • Dividend Yield
  • YHC N/A
  • EVOK N/A
  • EPS Growth
  • YHC N/A
  • EVOK N/A
  • EPS
  • YHC N/A
  • EVOK N/A
  • Revenue
  • YHC $2,390,517.00
  • EVOK $12,794,859.00
  • Revenue This Year
  • YHC $69.97
  • EVOK $57.38
  • Revenue Next Year
  • YHC $403.29
  • EVOK $59.57
  • P/E Ratio
  • YHC N/A
  • EVOK N/A
  • Revenue Growth
  • YHC 31.49
  • EVOK 70.02
  • 52 Week Low
  • YHC $0.68
  • EVOK $1.94
  • 52 Week High
  • YHC $98.00
  • EVOK $10.79
  • Technical
  • Relative Strength Index (RSI)
  • YHC 48.46
  • EVOK 84.11
  • Support Level
  • YHC $0.81
  • EVOK $4.50
  • Resistance Level
  • YHC $0.92
  • EVOK $10.73
  • Average True Range (ATR)
  • YHC 0.06
  • EVOK 0.25
  • MACD
  • YHC -0.00
  • EVOK 0.55
  • Stochastic Oscillator
  • YHC 23.08
  • EVOK 98.25

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: